MANUAL DE TOXICOLOGIA CLÍNICA - COVISA 2017(1)

Referências
ALVES, A.O.; et al. Canabinoides sintéticos: drogas de abuso emergentes.
Rev Psiq Clin.; v.39, n.4, p.142-148, 2012.
CASTANETO, M.S.; et al. Synthetic cannabinoids pharmacokinetics and
detection methods in biological matrices - Drug Metab Rev, v.47, n.2,
p.124-174.
Intoxicação por drogas de abuso
EMCDDA. Europe Monitoring Centre for Drugs and Drug Addiction.
Understanding the Spice Phenomenon. European Monitoring Centre for
Drugs and Drug Addiction. Disponível em:http: /www.emcdda.europa.eu/
attachements.cfm/att_80086_EN_Spice Thematic paper Acesso em: 01
jul. 2014.
MUSSELMAN, M.E.; HAMPTON, J.P. Not for human consumption: a review
of emerging designer drugs. Pharmacotherapy, v.34, p.745-757, 2014.
NELSON, M.E.; BRYANT, S.M; AKS, S.E. Emerging drugs of abuse. Emerg
Med Clin North Am, v.32, n.1, p.1-28, 2014.
ROSENBAUM, C.D.; CARREIRO, S.P.; BABU, K.M. Here today, gone
tomorrow. And back again? A review of herbal marijuana alternatives
(K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum,
methoxetamine, and piperazines. J Med Toxicol. v. 8, p.15-32, 2012.
UNODC. United Natios Office on Drugs and Crime. Synthetic cannabinoids
in herbal products. Disponível em: https: /www.unodc.org/documents/
scientific/Synthetic_Cannabinoids.pdf. Acesso em: 29 mar 2016.
WANG, G. S. Synthetic cannabinoids : Acute intoxication. In: UpToDate,
Post TW (Ed), UpToDate, Waltham, MA. Acesso em: 12 jun. 2015.
134
voltar ao menu